Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin

NCT06052176 is registered in ClinicalTrials.gov with Hunter Holmes Mcguire Veteran Affairs Medical Center as lead sponsor.

NCT NCT06052176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin
Lead sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 2, 2023
Completion date
December 1, 2026
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatic encephalopathy